Shares of NervGen Pharma (NASDAQ:NGEN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, one has assigned a buy […]

OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO – Get Free Report) has earned an average rating of “Hold” from the five research firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating on […]